IL13RA2 and glioblastoma: Although YYB-103 CAR T cells successfully killed IL13Rα2+ U87 cells in vitro, it was not clear whether they could kill GBM in the brain by penetrating the blood–brain barrier (BBB), which restricts the passage of peripheral immune cells.